Published in J Vet Intern Med on April 01, 2011
Treatment of chronically FIV-infected cats with suberoylanilide hydroxamic acid. Antiviral Res (2014) 0.77
Pharmacological inhibition of feline immunodeficiency virus (FIV). Viruses (2012) 0.76
Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection. Viruses (2012) 0.76
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol (1993) 2.00
Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr (1990) 1.59
Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis (1994) 1.53
Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res (2003) 1.51
2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J Feline Med Surg (2008) 1.43
Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet Immunol Immunopathol (1990) 1.23
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection. Vet Immunol Immunopathol (2008) 1.12
Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol (1993) 1.12
Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses (1997) 1.06
Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol (1992) 1.04
CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism. AIDS Res Hum Retroviruses (2010) 0.96
Is AZT/3TC therapy effective against FIV infection or immunopathogenesis? Vet Immunol Immunopathol (2002) 0.96
Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats. J Acquir Immune Defic Syndr (1993) 0.92
Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J Infect Dis (1998) 0.90
Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus. Antimicrob Agents Chemother (2000) 0.89
Low-dose interferon-alpha treatment for feline immunodeficiency virus infection. Vet Immunol Immunopathol (2005) 0.85
No major differences in the functional profile of HIV Gag and Nef-specific CD8+ responses between long-term nonprogressors and typical progressors. AIDS Res Hum Retroviruses (2008) 0.85
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy. J Acquir Immune Defic Syndr (2000) 0.84
In vivo antiretroviral activity of stampidine in chronically feline immunodeficiency virus-infected cats. Antimicrob Agents Chemother (2003) 0.83
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial. Antivir Ther (1997) 0.81
Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity. Antiviral Res (2001) 0.81
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290). Antivir Ther (1997) 0.81
Toxicity associated with high dosage 9-[(2R,5R-2,5-dihydro-5-phosphonomethoxy)-2-furanyl]adenine therapy off attempts to abort early FIV infection. Antiviral Res (1997) 0.80
Zidovudine toxicity to cats infected with feline leukemia virus. Fundam Appl Toxicol (1990) 0.80
Long-term treatment of diseased, FIV-seropositive field cats with azidothymidine (AZT). Zentralbl Veterinarmed A (1995) 0.79
Patient-physician trust: an exploratory study. J Fam Pract (1997) 3.63
Herpesvirus type 2: association with carcinoma of the cervix. Science (1968) 3.03
The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol (1969) 2.74
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46
Definitions of infection for surveillance in long-term care facilities. Am J Infect Control (1991) 2.33
Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial). Br J Surg (2009) 2.12
In vivo lymphocyte tropism of feline immunodeficiency virus. J Virol (1993) 2.00
Radiation hazards from Sellafield. Lancet (1993) 1.94
Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst (1974) 1.86
Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS (1990) 1.72
Inhibition of Anaphylactic Shock by Acetylsalicylic Acid. Science (1948) 1.65
Glucose-6-phosphate dehydrogenase mosaicism: ito;ozatopm om tje study of hair follicle variegation. Ann Hum Genet (1971) 1.64
Lesch-Nyhan syndrome: rapid detection of heterozygotes by use of hair follicles. Science (1971) 1.64
Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation (1999) 1.62
Prevention of rickets in Asian children: assessment of the Glasgow campaign. Br Med J (Clin Res Ed) (1985) 1.58
An in vitro measure of cellular immunity to fibroma virus. J Immunol (1970) 1.58
Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis (1994) 1.53
Effect of cold ischemic time and HLA matching in kidneys coming from "young" and "old" donors: do not leave for tomorrow what you can do tonight. Transplantation (2001) 1.50
Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl (2003) 1.41
Curiosity at Gale crater, Mars: characterization and analysis of the Rocknest sand shadow. Science (2013) 1.40
Systematic review of compression following treatment for varicose veins. Br J Surg (2015) 1.40
Effect of procedure volume on outcomes after iliac artery angioplasty and stenting. Br J Surg (2013) 1.39
Pattern of substance abuse in psychiatric inpatients. Can J Psychiatry (1991) 1.38
The saphenous veins--great and small or long and short? Eur J Vasc Endovasc Surg (2006) 1.37
Screening of pregnant women for evidence of current hepatitis B infection: selective or universal? Health Trends (1992) 1.35
Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation (1998) 1.31
Multiphasic checkup evaluation study. 1. Methods and population. Prev Med (1973) 1.30
The Caspar microsurgical discectomy and comparison with a conventional standard lumbar disc procedure. Neurosurgery (1991) 1.27
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr (1969) 1.24
Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet Immunol Immunopathol (1990) 1.23
ts1, a Paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture. J Virol (1985) 1.21
Cellular deoxyribonucleic acid synthesis and loss of contact inhibition in irradiated and contact-inhibited cell cultures infected with fibroma virus. J Virol (1969) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Specific macrophage immunity to vaccinia virus: macrophage-virus interaction. Infect Immun (1972) 1.19
Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Prev Med (1973) 1.14
Macrophage activation in congenitally athymic mice raised under conventional or germ-free conditions. J Reticuloendothel Soc (1977) 1.14
Innovation, NICE, and CardioQ. Br J Anaesth (2012) 1.14
Kinetic, structural, and spectroscopic identification of geminate states of myoglobin: a ligand binding site on the reaction pathway. Biochemistry (1987) 1.13
Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol (1993) 1.12
Influenza and pneumococcal vaccination and tuberculin skin testing programs in long-term care facilities: where do we stand? Infect Control Hosp Epidemiol (1995) 1.10
Absorption of irrigating fluid during laser photocoagulation of the endometrium in the treatment of menorrhagia. Br J Obstet Gynaecol (1989) 1.09
Choroid plexus macrophages proliferate and release toxic factors in response to feline immunodeficiency virus. J Neurovirol (2002) 1.08
DEC methods for appraising new drugs. Are a foundation for the nice appraisal committee. BMJ (1999) 1.07
Ethnic differences in the duration and amount of menstrual bleeding during the postmenarcheal period. Am J Epidemiol (1996) 1.05
Thrombosis, phlebitis, and varicose veins. BMJ (1996) 1.04
Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol (1994) 1.04
Comparison of the antinociceptive profiles of gabapentin and 3-methylgabapentin in rat models of acute and persistent pain: implications for mechanism of action. J Pharmacol Exp Ther (2005) 1.04
A prospective, multipractice study of shoulder function and health status in patients with documented rotator cuff tears. J Shoulder Elbow Surg (2001) 1.03
Infection of the choroid plexus by feline immunodeficiency virus. J Neurovirol (2002) 1.03
Swine influenza virus in swine and man in Illinois. J Occup Med (1981) 1.01
Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med (1991) 1.01
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. BJOG (2010) 1.00
Production of Antibody in Mammary Gland of Pregnant, Non-Lactating and Lactating Cows, Evoked by Polyvalent Antigen with Reference to Dosage and Frequency of Immunization. Can J Comp Med Vet Sci (1964) 1.00
Pharmacokinetic studies in animals of a new parenteral penem CP-65,207 and its oral prodrug ester. J Antibiot (Tokyo) (1990) 1.00
Effects of body fat on weight concerns, dating, and sexual activity: a longitudinal analysis of black and white adolescent girls. Dev Psychol (1999) 1.00
Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res (1999) 0.99
Evidence for the presence of thermophilic Fe(III)-reducing microorganisms in deep-sea hydrothermal vents at 13 degrees N (East Pacific Rise). FEMS Microbiol Ecol (2001) 0.99
Cytotoxic macrophages induced in hamsters by vaccinia virus: selective cytotoxicity for virus-infected targets by macrophages collected late after immunization. J Immunol (1979) 0.99
Influenza vaccination in long-term-care facilities: structuring programs for success. Infect Control Hosp Epidemiol (1999) 0.99
Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. Br Med J (Clin Res Ed) (1986) 0.99
The reproducibility of endometrial volume acquisition and measurement with the VOCAL-imaging program. Ultrasound Obstet Gynecol (2002) 0.98
Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation (1998) 0.98
Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro. J Reticuloendothel Soc (1974) 0.98
Induction of IL-2 and lymphokine activated killer cells in the cat. Vet Immunol Immunopathol (1987) 0.97
Characterization of surface antigen on cells infected by fibroma virus. J Immunol (1970) 0.97
Distal muscular dystrophy in an English family. Brain (1971) 0.96
Lymphocyte and macrophage responses after vaccinia virus infections. Infect Immun (1976) 0.96
Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol. Am J Obstet Gynecol (1984) 0.96
Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets. J Reticuloendothel Soc (1980) 0.96
Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol (1996) 0.95
Cytochrome P450 genes from Helicoverpa armigera: expression in a pyrethroid-susceptible and -resistant strain. Insect Biochem Mol Biol (1997) 0.94
Cytotoxic antibody response to tumors induced in adult and newborn rabbits by fibroma virus. Infect Immun (1972) 0.93
Myelin basic protein administration in multiple sclerosis. Arch Neurol (1973) 0.93
Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids. Neurology (1986) 0.93
Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo (1997) 0.93
Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23. Am J Hum Genet (2000) 0.93
Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J Infect Dis (1999) 0.93
Clinical pattern of perforated prepyloric and duodenal ulcer at Ile-Ife, Nigeria. Trop Doct (1998) 0.92
Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst (1986) 0.92
A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. Vet Immunol Immunopathol (1995) 0.92
Autochthonous, allogeneic, and exenogeneic cells as targets for vaccinia immune lymphocyte cytotoxicity. J Immunol (1978) 0.91
C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread. J Virol (2002) 0.91
Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur J Pharm Sci (1998) 0.90
Constitutive expression of types 1 and 2 cytokines by alveolar macrophages from feline immunodeficiency virus-infected cats. Vet Immunol Immunopathol (2001) 0.90
Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus. J Infect Dis (1998) 0.90
Testosterone and pubertal development as predictors of sexual activity: a panel analysis of adolescent males. Psychosom Med (1994) 0.90
Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology (1991) 0.90
Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus). J Virol (1995) 0.90
Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus. J Virol (1996) 0.89
Depressed cell-mediated immunity in newborn rabbits bearing fibroma virus-induced tumors. Infect Immun (1973) 0.89